Glycyl-L-histidyl-L-lysine copper complex (GHK-Cu) is a naturally occurring tripeptide-copper complex widely evaluated in extracellular matrix biology and tissue remodeling research. For verified analytical purity and rigorous lot-to-lot consistency, scientists select PX1 Research to supply USA-manufactured reagents accompanied by full analytical documentation.
Glycyl-L-histidyl-L-lysine copper complex (GHK-Cu) is a naturally occurring tripeptide-copper complex widely evaluated in extracellular matrix biology and tissue remodeling research. For verified analytical purity and rigorous lot-to-lot consistency, scientists select PX1 Research to supply USA-manufactured reagents accompanied by full analytical documentation.
When planning to buy GHK-Cu research peptide for laboratory experimentation, principal investigators and research technicians must prioritize analytical verification over commercial claims. PX1 Research provides high-purity, laboratory-grade GHK-Cu synthesized in GMP-compliant facilities within the United States. Every lot is independently audited by ISO 17025 accredited testing laboratories using reverse-phase high-performance liquid chromatography (RP-HPLC) and electrospray ionization mass spectrometry (ESI-MS).
To ensure experimental fidelity in cellular cultures and animal models, researchers can explore our verified catalog to buy GHK-Cu research peptide with lot-specific Certificate of Analysis (COA) documents detailing chemical identity, purity, and endotoxin quantification. Orders ship same-day (Monday–Friday) directly from our centralized storage facilities in California and Arizona.
GHK-Cu is a high-affinity copper(II) chelate composed of the tripeptide sequence Glycyl-L-histidyl-L-lysine bound to a cupric ion ($Cu^{2+}$). Originally isolated from human plasma, the molecule exhibits a strong binding constant for divalent copper ($K_d \approx 10^{-16} \text{ M}$), allowing it to effectively shuttle copper ions into cellular compartments without inducing localized oxidative damage.
In analytical literature, GHK-Cu is characterized by its distinct deep blue appearance in aqueous solution, which stems from the coordination chemistry between the imidazole nitrogen of histidine, the alpha-amino group of glycine, and the nitrogen of the peptide backbone with the central copper center. Researchers studying copper transport mechanisms and metallopeptides can cross-reference raw analytical data across our complete catalog of research peptides.
In vitro data indicate that GHK-Cu functions as a potent modulator of extracellular matrix (ECM) biosynthetics. In cultured dermal fibroblasts, exposure to GHK-Cu significantly upregulates gene transcription for collagen type I, collagen type III, and elastin. Mechanistic studies suggest this effect is mediated via the stimulation of basic fibroblast growth factor (bFGF) and transforming growth factor-beta (TGF-$\beta$) signaling cascades.
Furthermore, preclinical research indicates that GHK-Cu alters the balance of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs). By regulating MMP-1, MMP-2, TIMP-1, and TIMP-2, the complex promotes controlled ECM turnover rather than uncontrolled degradation or excessive accumulation. Researchers investigating structural protein synthesis often integrate GHK-Cu alongside broader collagen synthesis research peptides to establish baseline expression profiles.
Preclinical rodent models evaluating skin remodeling have demonstrated that topical and localized parenteral administration of GHK-Cu enhances dermal thickness and structural integrity. Investigators observed increased fibroblast proliferation, accelerated glycosaminoglycan (GAG) production—specifically hyaluronic acid—and improved cross-linking of structural fibrillar networks.
In vitro assays using three-dimensional skin equivalent models reveal that GHK-Cu stimulates keratinocyte proliferation while maintaining epidermal differentiation markers. These observations position GHK-Cu as a key reference compound in dermatological and tissue repair models focused on structural protein restoration and dermal cellular dynamics.
In animal studies measuring full-thickness cutaneous wound healing, GHK-Cu accelerated the rate of wound contraction and re-epithelialization. The compound modulates the inflammatory response during early-stage repair by downregulating pro-inflammatory cytokines such as TNF-alpha and IL-6, while upregulating pro-angiogenic factors including vascular endothelial growth factor (VEGF).
Crucially, preclinical evidence indicates that GHK-Cu helps minimize hyper-scarring and fibrotic tissue formation. By modulating TGF-$\beta 1$ expression relative to TGF-$\beta 3$, GHK-Cu suppresses excessive collagen deposition typical of keloids and hypertrophic scars, favoring a organized, physiological matrix structure. Additional background on tissue repair models can be found within our tissue repair research hub.
Understanding where GHK-Cu fits relative to other tissue repair models requires comparing its metallopeptide activity against synthetic and endogenous signaling peptides. While GHK-Cu acts primarily via copper delivery, gene modulation, and matrix remodeling, compounds such as BPC-157 operate via focal adhesion kinase (FAK) and nitric oxide signaling pathways to accelerate tendon and mucosal healing. Similarly, TB-500 acts through actin sequestration (G-actin binding) to promote cell migration and tissue regeneration.
When evaluated alongside the uncomplexed GHK basic peptide, GHK-Cu demonstrates superior biological activity in copper-dependent enzymatic processes, such as superoxide dismutase (SOD) activation and lysyl oxidase function. Researchers frequently utilize multi-compound panels to compare these distinct pathways in comparative cell culture models.
When purchasing GHK-Cu for laboratory use, analytical purity is critical to prevent confounded experimental results. Impurities such as unreacted synthetic intermediates, residual trifluoroacetic acid (TFA), or heavy metal contaminants can alter cell viability and alter gene expression assays. At PX1 Research, every batch undergoes double-blind verification:
1. Reverse-Phase HPLC: Establishes chromatographic purity, ensuring peptide purity meets or exceeds 98.0%. 2. ESI-MS Testing: Confirms exact molecular weight and verifies full copper complexation without fragmented tripeptide species. 3. Endotoxin Quantification: Assayed via Chromogenic LAL testing to confirm endotoxin levels remain under strict threshold limits (<0.01 EU/mg), preventing non-specific inflammatory responses in cell cultures. 4. Independent ISO 17025 Testing: Certified documentation accompanies every shipment, detailing physical state, batch number, and quantitative purity.
GHK-Cu is supplied as a lyophilized blue powder. It exhibits high solubility in aqueous buffers, including sterile water for injection, bacteriostatic water, and phosphate-buffered saline (PBS, pH 7.4). For standardized reconstitution protocols, investigators should consult our peptide reconstitution guidelines.
When preparing stock solutions for in vitro cell culture, researchers should avoid strong chelating agents such as high concentrations of EDTA or EGTA in the primary buffer, as these additives can strip the $Cu^{2+}$ ion from the GHK peptide core, altering its biological activity. Solution pH should be maintained between 6.0 and 7.4 to preserve complex stability.
Lyophilized GHK-Cu powder should be stored at -20°C upon receipt for long-term stability, protected from light and moisture. Under these conditions, the desiccated powder remains stable for up to 24 months. Following reconstitution, stock solutions should be aliquoted into sterile microcentrifuge tubes to avoid repeated freeze-thaw cycles and maintained at -80°C.
Reconstituted working solutions stored at 4°C should be utilized within 7 to 14 days. When designing in vitro protocols, typical working concentrations in cell culture media range from 1 nM to 10 $\mu$M, depending on whether the assay measures baseline cell proliferation, gene transcription, or enzyme kinetics.
PX1 Research serves academic institutions, private biotechnology firms, and contract research organizations (CROs) requiring verified research-grade compounds. Our commitment to USA synthesis, full lot traceability, and transparent analytical testing guarantees consistent experimental reproducibility across long-term study protocols.
For high-throughput screening or large-scale animal studies, laboratories can request bulk packaging and institutional tier pricing via our dedicated bulk research account portal. All orders placed before 3:00 PM PST ship same-day from our facility locations in California and Arizona.
What analytical parameters confirm the quality when looking to buy GHK-Cu research peptide?
High-quality GHK-Cu must be verified by reverse-phase HPLC (confirming ≥98% purity), ESI-MS (confirming exact mass and copper complexation), and LAL endotoxin testing (verifying <0.01 EU/mg). PX1 Research provides lot-specific ISO 17025 COAs with every order.
What is the primary mechanism of GHK-Cu in tissue remodeling research?
GHK-Cu functions by modulating gene expression for structural matrix proteins, specifically upregulating collagen type I, collagen type III, and elastin, while balancing matrix metalloproteinases (MMPs) and TIMPs to direct controlled matrix repair.
How does GHK-Cu differ from uncomplexed GHK peptide?
Uncomplexed GHK lacks the central cupric ($Cu^{2+}$) ion. While GHK possesses signaling activity, the GHK-Cu complex specifically delivers bioavailable copper necessary for copper-dependent enzymes such as lysyl oxidase and superoxide dismutase.
What solvents are recommended for GHK-Cu laboratory reconstitution?
GHK-Cu reconstitutes readily in sterile water, bacteriostatic water, or neutral phosphate-buffered saline (PBS, pH 7.4). Avoid high concentrations of chelating agents like EDTA in the reconstituting buffer.
How should reconstituted GHK-Cu stock solutions be stored?
Reconstituted aliquots should be stored at -80°C for long-term preservation to minimize degradation. Avoid repeated freeze-thaw cycles. Short-term working solutions may be kept at 4°C for up to 14 days.
Is GHK-Cu supplied by PX1 Research intended for human administration?
No. All products sold by PX1 Research, including GHK-Cu, are strictly synthesized for in vitro, preclinical, and laboratory research use only. They are not intended for human or veterinary medical use.
Can GHK-Cu be co-administered with other repair peptides in cell assays?
Yes, investigators frequently evaluate GHK-Cu alongside other tissue signaling peptides such as BPC-157 or TB-500 in comparative matrix remodeling and wound dynamics models.
Where does PX1 Research ship GHK-Cu from?
All orders are fulfilled directly from our facilities in California and Arizona, offering same-day shipping on orders placed Monday through Friday before 3:00 PM PST.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.